Esther Rajavelu - Chief Executive Officer, Chief Financial Officer and Chief Business Officer at Spero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Stock Symbol
SPRO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Esther Rajavelu - trading volume in the past year for Spero Therapeutics, Inc.

Holdings reported by Esther Rajavelu for Spero Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 910K $655K $0.72 May 2, 2025 Direct

Transactions reported by Esther Rajavelu for Spero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.